An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning influenza
Updated Jan 2, 2026
FDA revokes Emergency Use Authorizations for the Lucira by Pfizer COVID-19 & Flu Test and the Lucira by Pfizer COVID-19 & Flu Home Test at the request of Pfizer Inc. The decision reflects ongoing evaluations of diagnostic device efficacy and safety.
A CDC report highlights that many flu-related deaths in children and teens could have been prevented with vaccination. While fatalities are rare, the findings emphasize the importance of flu vaccination in this age group.
FDA has authorized a new diagnostic lab test developed by the CDC for detecting human infections with seasonal influenza viruses and novel influenza A viruses. This test aims to enhance the ability to identify potential pandemic threats.
CDC will hold a telebriefing to discuss this season's influenza vaccination recommendations and coverage among healthcare personnel and pregnant women. This initiative aims to enhance awareness and improve vaccination rates.
National Influenza Vaccination Week will emphasize the importance of flu vaccination among young adults aged 19-24. The CDC plans to utilize social media outreach to engage this demographic effectively.